ClinVar Miner

Submissions for variant NM_001243279.3(ACSF3):c.1407_1408del (p.Gly470fs)

dbSNP: rs1912702795
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001230340 SCV001402815 likely pathogenic Combined malonic and methylmalonic acidemia 2019-09-25 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg558 amino acid residue in ACSF3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21841779, 26827111, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has not been reported in the literature in individuals with ACSF3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the ACSF3 gene (p.Gly470Profs*95). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 107 amino acids of the ACSF3 protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.